SATT PACA CORSE has floated a tender for Contract notice: Research and development services and related consultancy services. The project location is France and the tender is closing on 09 Sep 2019. The tender notice number is 359783-2019, while the TOT Ref Number is 35169577. Bidders can have further information about the Tender and can request the complete Tender document by Registering on the site.

Expired Tender

Procurement Summary

Country : France

Summary : Contract notice: Research and development services and related consultancy services

Deadline : 09 Sep 2019

Other Information

Notice Type : Tender

TOT Ref.No.: 35169577

Document Ref. No. : 359783-2019

Competition : ICB

Financier : Self Financed

Purchaser Ownership : -

Tender Value : Refer Document

Purchaser's Detail

Purchaser : SATT PACA CORSE
Office Name: SATT PACA Corse
Address: 35 quai du Lazaret — CS 70545
Town: Marseille
Postal Code: 13304


Phone: +33 763041550

France
Email :berengere.marty@sattse.com
URL :http://www.sattse.com/

Tender Details

Object of the contract
Research and development services and related consultancy services

Description: Contract notice: Research and development services and related consultancy services

Authority Type: Other
Contact Nature: Services
Procedure: Open procedure
Document: Contract notice
Regulation: European Union, with participation by GPA countries
Award criteria: The most economic tender
CPV code: 73000000, 73000000
CPV Description: Research and development services and related consultancy services.

Production d`anticorps specifiques — Antibody sequencing, molecular cloning and production of recombinant, chimeric and humanized antibodies

Reference Number : CC2019004-1122

Les prestations sont reparties en 7 Work Packages:

Les prestations sont reparties en 7 Work Packages:

— WP1: antibody sequencing and molecular cloning, production of recombinant antibodies,

— WP2: production and purification of 300 mg recombinant antibody,

— WP3: production of 6 chimeric mAbs benchmark mAb for in vivo studies (50mg scale),

— WP4: humanization of 3 mAbs candidates,

— WP5: determination of affinity by any relevant technology (SPR, interferometry, etc.) on recombinant target of interest (up to 48 humanization variants),

— WP6: proin vitro and in vivo studies (50 mg scale),

- WP7: production and purification of 400 mg recombinant humanized antibody.

Registration in the Trade Register.

Applicants must submit their application and offers electronically on the buyer profile.

The technical merit criterion of the offer will be assessed according to the following weighted criteria- the quality of the human resources selected: organization chart, detailed profile (qualification, experience) and detailed role of each presenter (40%), - quality of the methodology used (40%), - quality of resources materials and tools implemented (20%).


Internet address (URL): http://www.sattse.com/

Documents

 Tender Notice